ALDX logo

Aldeyra Therapeutics (ALDX) Company Overview

Profile

Full Name:

Aldeyra Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 2, 2014

Indexes:

Not included

Description:

Aldeyra Therapeutics (ALDX) is a biotechnology company focused on developing innovative treatments for eye diseases and other conditions. They aim to address unmet medical needs through their research on novel therapies, particularly those targeting inflammation and cell signaling pathways.

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 9, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Aug 9, 24 HC Wainwright & Co.
Buy
Aug 2, 24 HC Wainwright & Co.
Buy
May 6, 24 Oppenheimer
Outperform
May 6, 24 HC Wainwright & Co.
Buy
Apr 3, 24 Oppenheimer
Outperform
Oct 17, 23 Oppenheimer
Perform
Oct 17, 23 Citigroup
Buy
Aug 9, 23 Oppenheimer
Outperform
Jun 30, 23 HC Wainwright & Co.
Buy
Jun 22, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Aldeyra Therapeutics?
  • Does Aldeyra Therapeutics pay dividends?
  • What sector is Aldeyra Therapeutics in?
  • What industry is Aldeyra Therapeutics in?
  • What country is Aldeyra Therapeutics based in?
  • When did Aldeyra Therapeutics go public?
  • Is Aldeyra Therapeutics in the S&P 500?
  • Is Aldeyra Therapeutics in the NASDAQ 100?
  • Is Aldeyra Therapeutics in the Dow Jones?
  • When was Aldeyra Therapeutics's last earnings report?
  • When does Aldeyra Therapeutics report earnings?
  • Should I buy Aldeyra Therapeutics stock now?

What is the ticker symbol for Aldeyra Therapeutics?

The ticker symbol for Aldeyra Therapeutics is NASDAQ:ALDX

Does Aldeyra Therapeutics pay dividends?

No, Aldeyra Therapeutics does not pay dividends

What sector is Aldeyra Therapeutics in?

Aldeyra Therapeutics is in the Healthcare sector

What industry is Aldeyra Therapeutics in?

Aldeyra Therapeutics is in the Biotechnology industry

What country is Aldeyra Therapeutics based in?

Aldeyra Therapeutics is headquartered in United States

When did Aldeyra Therapeutics go public?

Aldeyra Therapeutics's initial public offering (IPO) was on May 2, 2014

Is Aldeyra Therapeutics in the S&P 500?

No, Aldeyra Therapeutics is not included in the S&P 500 index

Is Aldeyra Therapeutics in the NASDAQ 100?

No, Aldeyra Therapeutics is not included in the NASDAQ 100 index

Is Aldeyra Therapeutics in the Dow Jones?

No, Aldeyra Therapeutics is not included in the Dow Jones index

When was Aldeyra Therapeutics's last earnings report?

Aldeyra Therapeutics's most recent earnings report was on Nov 7, 2024

When does Aldeyra Therapeutics report earnings?

The next expected earnings date for Aldeyra Therapeutics is May 2, 2025

Should I buy Aldeyra Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions